No headlines found.
Fortress Biotech to Participate in A.G.P.'s Annual Virtual Healthcare Conference
Globe Newswire (Mon, 18-May 8:30 AM ET)
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Globe Newswire (Thu, 14-May 4:10 PM ET)
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
Globe Newswire (Mon, 4-May 8:30 AM ET)
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
Globe Newswire (Tue, 31-Mar 4:05 PM ET)
Globe Newswire (Mon, 30-Mar 4:05 PM ET)
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock trades on the NASDAQ stock market under the symbol FBIOP.
As of June 12, 2026, FBIOP stock price climbed to $20.71 with 42,845 million shares trading.
FBIOP has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, FBIOP traded as high as $21.23 and as low as $4.72.
FBIOP has outperformed the market in the last year with a price return of +135.5% while the SPY ETF gained +24.1%. FBIOP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +55.7% and +6.4%, respectively, while the SPY returned +11.6% and -1.9%, respectively.
FBIOP support price is $19.75 and resistance is $21.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBIOP shares will trade within this expected range on the day.
